-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Ethical issues of placebo-controlled clinical trials in multiple sclerosis
Jeffrey A Cohen
Interview: Clinical Investigation
-
Ethical issues of placebo-controlled clinical trials in multiple sclerosis
Jeffrey A Cohen
Interview: Clinical Investigation
-
Ethical issues of placebo-controlled clinical trials in multiple sclerosis
Jeffrey A Cohen
Interview: Clinical Investigation
-
Ethical issues of placebo-controlled clinical trials in multiple sclerosis
Jeffrey A Cohen
Interview: Clinical Investigation
-
Ethical issues of placebo-controlled clinical trials in multiple sclerosis
Jeffrey A Cohen
Interview: Clinical Investigation
-
Ethical issues of placebo-controlled clinical trials in multiple sclerosis
Jeffrey A Cohen
Interview: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation